These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 17614734)
1. Fluorescence and absorption assessment of a lipid mTHPC formulation following topical application in a non-melanotic skin tumor model. Johansson A; Svensson J; Bendsoe N; Svanberg K; Alexandratou E; Kyriazi M; Yova D; Gräfe S; Trebst T; Andersson-Engels S J Biomed Opt; 2007; 12(3):034026. PubMed ID: 17614734 [TBL] [Abstract][Full Text] [Related]
2. Fluorescence monitoring of a topically applied liposomal Temoporfin formulation and photodynamic therapy of nonpigmented skin malignancies. Bendsoe N; Persson L; Johansson A; Axelsson J; Svensson J; Gräfe S; Trebst T; Andersson-Engels S; Svanberg S; Svanberg K J Environ Pathol Toxicol Oncol; 2007; 26(2):117-26. PubMed ID: 17725537 [TBL] [Abstract][Full Text] [Related]
3. Tumor selectivity at short times following systemic administration of a liposomal temoporfin formulation in a murine tumor model. Svensson J; Johansson A; Gräfe S; Gitter B; Trebst T; Bendsoe N; Andersson-Engels S; Svanberg K Photochem Photobiol; 2007; 83(5):1211-9. PubMed ID: 17880517 [TBL] [Abstract][Full Text] [Related]
4. Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. Dragicevic-Curic N; Gräfe S; Albrecht V; Fahr A J Photochem Photobiol B; 2008 Apr; 91(1):41-50. PubMed ID: 18316200 [TBL] [Abstract][Full Text] [Related]
5. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model. de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of temoporfin-loaded invasomes in the photodynamic therapy in human epidermoid and colorectal tumour cell lines. Dragicevic-Curic N; Gräfe S; Gitter B; Fahr A J Photochem Photobiol B; 2010 Dec; 101(3):238-50. PubMed ID: 20797872 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic and biodistribution study following systemic administration of Fospeg®--a Pegylated liposomal mTHPC formulation in a murine model. Xie H; Svenmarker P; Axelsson J; Gräfe S; Kyriazi M; Bendsoe N; Andersson-Engels S; Svanberg K J Biophotonics; 2015 Jan; 8(1-2):142-52. PubMed ID: 24375973 [TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with intratumoral administration of Lipid-Based mTHPC in a model of breast cancer recurrence. D'Hallewin MA; Kochetkov D; Viry-Babel Y; Leroux A; Werkmeister E; Dumas D; Gräfe S; Zorin V; Guillemin F; Bezdetnaya L Lasers Surg Med; 2008 Oct; 40(8):543-9. PubMed ID: 18798287 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: comparison with clinical measurements. Glanzmann T; Forrer M; Blant SA; Woodtli A; Grosjean P; Braichotte D; van den Bergh H; Monnier P; Wagnières G J Photochem Photobiol B; 2000 Aug; 57(1):22-32. PubMed ID: 11100834 [TBL] [Abstract][Full Text] [Related]
10. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in Hairless mice (SKH-1) by fluorescence spectroscopy. Bossu E; Padilla-Ybarra JJ; Notter D; Vigneron C; Guillemin F Anticancer Drugs; 2000 Feb; 11(2):85-91. PubMed ID: 10789590 [TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
12. Liposomes in topical photodynamic therapy. Dragicevic-Curic N; Fahr A Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896 [TBL] [Abstract][Full Text] [Related]
13. Influence of incubation time and sensitizer localization on meta-tetra(hydroxyphenyl)chlorin (mTHPC)-induced photoinactivation of cells. Sasnouski S; Pic E; Dumas D; Zorin V; D'Hallewin MA; Guillemin F; Bezdetnaya L Radiat Res; 2007 Aug; 168(2):209-17. PubMed ID: 17638401 [TBL] [Abstract][Full Text] [Related]
14. Correlation between in vivo pharmacokinetics, intratumoral distribution and photodynamic efficiency of liposomal mTHPC. Lassalle HP; Dumas D; Gräfe S; D'Hallewin MA; Guillemin F; Bezdetnaya L J Control Release; 2009 Mar; 134(2):118-24. PubMed ID: 19100297 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours. Boiy A; Roelandts R; de Witte PA J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetic behavior of the photosensitizer meso-tetra-hydroxyphenyl-chlorin in mice and men. Triesscheijn M; Ruevekamp M; Out R; Van Berkel TJ; Schellens J; Baas P; Stewart FA Cancer Chemother Pharmacol; 2007 Jun; 60(1):113-22. PubMed ID: 17009028 [TBL] [Abstract][Full Text] [Related]
17. Macrophage selective photodynamic therapy by meta-tetra(hydroxyphenyl)chlorin loaded polymeric micelles: A possible treatment for cardiovascular diseases. Wennink JWH; Liu Y; Mäkinen PI; Setaro F; de la Escosura A; Bourajjaj M; Lappalainen JP; Holappa LP; van den Dikkenberg JB; Al Fartousi M; Trohopoulos PN; Ylä-Herttuala S; Torres T; Hennink WE; van Nostrum CF Eur J Pharm Sci; 2017 Sep; 107():112-125. PubMed ID: 28679107 [TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with meso-tetra(hydroxyphenyl) chlorin in the topical treatment of Bowen's disease and basal cell carcinoma. Gupta G; Morton CA; Whitehurst C; Moore JV; MacKie RM Br J Dermatol; 1999 Aug; 141(2):385-6. PubMed ID: 10468840 [No Abstract] [Full Text] [Related]
19. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model. Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244 [TBL] [Abstract][Full Text] [Related]
20. Biodistribution of the photosensitizer temoporfin after in vivo topical application of temoporfin-loaded invasomes in mice bearing subcutaneously implanted HT29 tumor. Dragicevic N; Nikolic B; Albrecht V; Fahr A Int J Pharm; 2022 Dec; 629():122374. PubMed ID: 36351505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]